InvestorsHub Logo
Followers 16
Posts 329
Boards Moderated 0
Alias Born 01/21/2016

Re: None

Friday, 08/26/2016 1:12:04 PM

Friday, August 26, 2016 1:12:04 PM

Post# of 402526
@Couch, lasers, n2

Just a quick observation and question for you guys. Given that the generic that we are waiting for approval from the FDA is for percocet, could the same lots of oxycodone be used in the one bead of ELI-200, once approved? (Aside from expiration dates) Or do they have to be registered and produced differently to meet different specs?

My thought process is that this is Nasrat's way of starting production and/or acquisition of a big stockpile of the API oxycodone, to be used for the generic ANDA once approved. Then once ELI-200 gets approval, quickly divert some of that stock API to initiate SequestOx sales ASAP.

One of the thoughts I have been pondering for some time, as nasrat said he wanted to get Sequest to market as quickly as possible, but did not want to manufacture products that would expire on the shelf before going out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News